Drug Database
Back to search

Czechia· CZ-0210038

SYLVANT

A siltuximab product containing siltuximab, registered in Czechia by Recordati Netherlands B.V., Schiphol-Rijk. The same ATC class is registered in 14 of our 19 countries.

ATC L04AC11

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedSYLVANTATCL04AC11REGISTER NO.CZ-0210038PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about siltuximabAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Siltuximab is registered in 14 of 19 countries.

Countries holding a registration under ATC L04AC11 (siltuximab), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 9 of them publish a price we can compare per daily dose
Search siltuximab products by name

Siltuximab · ATC L04AC11

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
SILTUXIMAB
Manufacturer
Recordati Netherlands B.V., Schiphol-Rijk
Country
Czechia (CZ)
ATC code
L04AC11
ATC class
Siltuximab
Defined daily dose
37 mg, P
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • cz_kod_sukl
    0210038
    1
    CZK 53799.5

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

151 interactions on record for siltuximab.

Graded by severity as the source publishes them — 28 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check siltuximab against other medicinesHow interaction checks work

Siltuximab · interactions on record

151 records

  • 28 severe
  • 116 moderate
  • 7 minor

Most severe, free to view

  • CladribineL01BB04severe
  • Talimogene laherparepvecL01XL02severe
  • Talimogen laherparepvecL01XX51severe
  • LeflunomidL04AA13severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Siltuximab in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All siltuximab products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Sylvant
  • Liechtenstein · Sylvant
  • Norway · Sylvant

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/694dfd3c-52cb-4266-af60-772103da3e2b
GET /v1/drugs/694dfd3c-52cb-4266-af60-772103da3e2b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "INF PLV CSL",
  "source": "sukl",
  "strength": "400MG",
  "pack_size": "1",
  "substance": "SILTUXIMAB",
  "cz_kod_sukl": "0210038",
  "product_type": "BT",
  "substance_codes": "18482",
  "registration_state": "R",
  "registration_number": "EU/1/14/928/002"
}
API referenceMCP serverPlans

See everything about siltuximab.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console